Models of gaze allocation in complex scenes are derived mainly from studies of static picture viewing. The dominant framework to emerge has been image salience, where properties of the stimulus play ...a crucial role in guiding the eyes. However, salience-based schemes are poor at accounting for many aspects of picture viewing and can fail dramatically in the context of natural task performance. These failures have led to the development of new models of gaze allocation in scene viewing that address a number of these issues. However, models based on the picture-viewing paradigm are unlikely to generalize to a broader range of experimental contexts, because the stimulus context is limited, and the dynamic, task-driven nature of vision is not represented. We argue that there is a need to move away from this class of model and find the principles that govern gaze allocation in a broader range of settings. We outline the major limitations of salience-based selection schemes and highlight what we have learned from studies of gaze allocation in natural vision. Clear principles of selection are found across many instances of natural vision and these are not the principles that might be expected from picture-viewing studies. We discuss the emerging theoretical framework for gaze allocation on the basis of reward maximization and uncertainty reduction.
While cigarette smoking has declined among the U.S. general population, sale and use of non-cigarette alternative tobacco products (ATP; e.g., e-cigarettes, cigars) and dual use of cigarettes/ATPs ...are rising. Little is known about ATP use patterns in cancer survivors enrolled in clinical trials. We investigated prevalence of tobacco product use, and factors associated with past 30-day use, among patients with cancer in national trials.
Cancer survivors (N = 756) enrolled in 9 ECOG-ACRIN clinical trials (2017-2021) completed a modified Cancer Patient Tobacco Use Questionnaire (C-TUQ) which assessed baseline cigarette and ATP use since cancer diagnosis and in the past 30 days.
Patients were on average 59 years old, 70% male, and the mean time since cancer diagnosis was 26 months. Since diagnosis, cigarettes (21%) were the most common tobacco product used, followed by smokeless tobacco use (5%), cigars (4%), and e-cigarettes (2%). In the past 30 days, 12% of patients reported smoking cigarettes, 4% cigars, 4% using smokeless tobacco, and 2% e-cigarettes. Since cancer diagnosis, 5.5% of the sample reported multiple tobacco product use, and 3.0% reported multiple product use in the past 30 days. Males (vs. females; OR 4.33; P = 0 < 0.01) and individuals not living with another person who smokes (vs. living with; OR, 8.07; P = 0 < 0.01) were more likely to use ATPs only versus cigarettes only in the past 30 days.
Among patients with cancer, cigarettes were the most prevalent tobacco product reported.
Regardless, ATPs and multiple tobacco product use should be routinely assessed in cancer care settings.
PDF
